Epic Pharma. LLC.
FDA Inspections Database

Epic Pharma. LLC.

FDA Inspections Database

U.S. FDA inspection classifications and citation records from the official FDA inspection database.

NAI · No Action IndicatedVAI · Voluntary Action Indicated United States
  • Total Records 13
  • Latest Inspection 2023-12-07
  • Data Source U.S. FDA
  • Last Updated 2024-04-01

13

All
View

6

NAI
View

7

VAI
View
Company Overview

Company

Epic Pharma. LLC.

Country

U.S.A

Social Profiles

Company Snapshot

Epic Pharma. LLC.

227-15 N. Conduit Ave.Laurelton, NY 11413, USA

U.S.A

www.epic-pharma.com/ E.Korzik@Epic-Pharma.com View on Map
FDA Inspections Timeline (13 records)
2023
07 Dec
No Action Indicated NAI

Legal Name

Epic Pharma, LLC

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2023-12-07

FMD Date

2024-04-01

Fiscal Year

2024

State

New York

Laurelton, United States

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2024
Citations: No

2023
23 Oct
Voluntary Action Indicated VAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2023-10-23

FMD Date

2023-11-17

Fiscal Year

2024

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2024
Citations: Yes

2019
01 Feb
Voluntary Action Indicated VAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2019-02-01

FMD Date

2019-03-07

Fiscal Year

2019

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2019
Citations: Yes

2018
06 Nov
Voluntary Action Indicated VAI

Legal Name

Epic Pharma, LLC

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2018-11-06

FMD Date

-

Fiscal Year

2019

State

New York

Laurelton, United States

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2019
Citations: Yes

2017
21 Apr
Voluntary Action Indicated VAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2017-04-21

FMD Date

2015-06-23

Fiscal Year

2017

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2017
Citations: Yes

2015
04 Jun
Voluntary Action Indicated VAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2015-06-04

FMD Date

-

Fiscal Year

2015

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2015
Citations: Yes

2013
23 Dec
No Action Indicated NAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2013-12-23

FMD Date

-

Fiscal Year

2014

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2014
Citations: No

2012
01 Nov
No Action Indicated NAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2012-11-01

FMD Date

-

Fiscal Year

2013

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2013
Citations: No

2011
13 Oct
No Action Indicated NAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2011-10-13

FMD Date

-

Fiscal Year

2012

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2012
Citations: No

2011
13 Oct
Voluntary Action Indicated VAI

Legal Name

Epic Pharma, LLC

Project Area

Unapproved and Misbranded Drugs

Product Type

Drugs

Posted Citations

No

Inspection End Date

2011-10-13

FMD Date

-

Fiscal Year

2012

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2012
Citations: No

2010
16 Nov
Voluntary Action Indicated VAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2010-11-16

FMD Date

-

Fiscal Year

2011

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2011
Citations: Yes

2010
05 Mar
No Action Indicated NAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2010-03-05

FMD Date

-

Fiscal Year

2010

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2010
Citations: No

2008
14 Nov
No Action Indicated NAI

Legal Name

Epic Pharma, LLC

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2008-11-14

FMD Date

-

Fiscal Year

2009

State

New York

Laurelton, United States

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2009
Citations: No

Related Databases
  • FDA Inspections
    13 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    360 View
  • Drug Prices in Switzerland
    0 View
Classification Breakdown
13 total
  • NAI (No Action Indicated)
  • VAI (Voluntary Action Indicated)
Official Source

All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.

Visit FDA.gov
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Location

Laurelton, New York, United States

Inspection Info

Fiscal Year: 2024
Citations: No

100% Official Data

Directly from the U.S. FDA inspection database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

FDA inspection data is compiled from publicly available U.S. FDA inspection classification records.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.